Related Experiment Videos
A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis
1Department of Medicine, Gentofte University Hospital, Denmark.
Abstract:
A sequential histological study of bone marrow biopsies from 36 patients with idiopathic myelofibrosis was performed to investigate the accumulation of connective tissue in the bone marrow during the course of the disease and the influence of therapy on this process. The degree of bone marrow fibrosis was graded semiquantitatively from 0 (normal) to +5 (extensive collagen fibrosis and ostemyelosclerosis). The median interval between the first and final biopsy was 25 months (range 3 to 103) in patients with chronic idiopathic myelofibrosis and 2 months (range 1 to 14) in patients with a syndrome of acute myelofibrosis. In most patients with chronic IMF the bone marrow fibrosis remained unchanged. Regression of bone marrow fibrosis in 9 patients with chronic IMF was associated with immunosuppressive/-cytotoxic treatment or splenectomy. Severe bone marrow fibrosis completely resolved during intensive chemotherapy of a patient with acute myelofibrosis. No relationship existed between spleen size and the degree of bone marrow fibrosis.
Insights
Idiopathic myelofibrosis bone marrow fibrosis can regress with specific treatments like immunosuppressants, splenectomy, or chemotherapy. However, in most chronic cases, fibrosis remains stable.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Idiopathic myelofibrosis (IMF) is characterized by bone marrow fibrosis.
- Understanding fibrosis progression and treatment impact is crucial for patient management.
Purpose of the Study:
- To investigate connective tissue accumulation in bone marrow during idiopathic myelofibrosis.
- To evaluate the influence of therapy on bone marrow fibrosis in IMF patients.
Main Methods:
- Sequential histological analysis of bone marrow biopsies from 36 patients.
- Semiquantitative grading of bone marrow fibrosis (0-5 scale).
- Tracking fibrosis changes over median follow-up periods of 25 months (chronic) and 2 months (acute).
Main Results:
- Bone marrow fibrosis remained largely unchanged in most chronic IMF patients.
- Fibrosis regression observed in 9 chronic IMF patients treated with immunosuppressants/cytotoxics or splenectomy.
- Complete resolution of severe fibrosis occurred in one acute IMF patient with intensive chemotherapy.
- No correlation found between spleen size and bone marrow fibrosis degree.
Conclusions:
- Therapeutic interventions, including immunosuppressive/cytotoxic agents, splenectomy, and chemotherapy, can induce regression of bone marrow fibrosis in idiopathic myelofibrosis.
- Bone marrow fibrosis in chronic IMF is often stable, but treatment offers potential for reversal.
- Spleen size is not a reliable indicator of fibrosis severity in IMF.